OSE Immunotherapeutics reports 24,825,111 issued shares as of Sept. 30, 2026
Bitget2026/10/07 16:01OSE Immunotherapeutics reported 24,825,111 issued shares as of Sept. 30, 2026. Theoretical voting rights totaled 29,492,461. Exercisable voting rights stood at 29,390,007. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSE Immunotherapeutics SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610071200OMX_____CNEWS_FR_GNW1001276771_fr) on October 07, 2026, and is solely responsible for the information contained therein.
- OSE Immunotherapeutics reported 24,825,111 issued shares as of Sept. 30, 2026.
- Theoretical voting rights totaled 29,492,461.
- Exercisable voting rights stood at 29,390,007.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
